Skip to main content
. 2007 Feb 28;104(10):4101–4105. doi: 10.1073/pnas.0700004104

Table 1.

AIP mutations identified in pituitary adenoma patients from the European and North American populations

Patients Mutation* Fragment No of patients with AIP mutation (%) Clinical data Normal AIP allele lost in tumor Sex Age at diagnosis, years Family history of pituitary adenoma Controls
Young acromegaly
    Germany c.66-71delAGGAGA Exon 1 1 of 27 (3.7) Acromegaly-GHoma Yes M 20 Yes (acromegaly) 0 of 532
c.878-879AG→GT (p.E293G) and c.880→891delCTGGACCCAGCC Exon 6 1of 27 (3.7) Acromegaly-GHoma Yes F 29 NA 0 of 255
    Finland c.40C→T (p.Q14X) Exon 1 2 of 36 (5.5) Acromegaly-GHoma NA M 36 No 0 of 532
Acromegaly-GHoma NA F 41 No 0 of 532
Unselected acromegaly
    Italy 0 of 71
Unselected pituitary adenoma
    U.S. IVS2-1G→C Intron 2 1 of 113 (0.9) Acromegaly-GHoma NA M 20 No 0 of 202
c.824-825insA Exon 6 1 of 113 (0.9) GHoma Yes M 8 No 0 of 201
    Poland c.911G→A (p.R304Q) Exon 6 1 of 122 (0.8) Cushing's disease–ACTHoma NA NA 26 No 0 of 255
MEN1-negative
    Spain c.542delT Exon 4 1 of 55 (1.8) Acromegaly–GHoma NA M 18 Yes (acromegaly) 0 of 203
    The Netherlands c.896C→T (p.A299V) Exon 6 1 of 36 (2.8) Acromegaly–GHoma NA F 16 No 0 of 255

ACTHoma, ACTH-secreting adenoma; F, female; GHoma, GH-secreting adenoma; M, male; NA, not available.

*Only putative pathogenic changes are depicted.

Age at time of operation; age at time of diagnosis is not known.